Blog
RSS FeedPosted by Michael Wonder on 20 Mar 2017
HCF launches tool that calculates procedural costs, names doctors who charge extra
20 March 2017 - Private health customers are confused about what to expect financially from common procedures and are in ...
Posted by Michael Wonder on 20 Mar 2017
Chemotherapy compounding payment scheme - extension to the non-mandatory claiming period
17 March 2017 - The proposed date for mandatory inclusion of the Compounder ID with eligible EFC claims is being ...
Posted by Michael Wonder on 18 Mar 2017
CAR-T drugs worth up to $649K in childhood leukaemia, says U.K. report
17 March 2017 - Health authorities in Britain ran cost-effectiveness numbers on pioneering CAR-T therapies that might be used to ...
Posted by Michael Wonder on 18 Mar 2017
Additional public summary documents from the November 2016 PBAC meeting
17 March 2017 - The public summary documents (first time rejections and deferrals) from the November 2016 PBAC meeting are ...
Posted by Michael Wonder on 17 Mar 2017
Cystic fibrosis advocates push for affordable access to Orkambi only drug available in Australia
17 March 2017 - Cystic fibrosis patients should be given immediate and free access to the only drug available in ...
Posted by Michael Wonder on 17 Mar 2017
NICE recommends longer-lasting battery technology for implantable heart rhythm devices
17 March 2017 - People with heart failure are set to benefit from longer-lasting battery technology in implantable heart rhythm devices, ...
Posted by Michael Wonder on 17 Mar 2017
NICE publishes draft guidance on the use of daratumumab (Darzalex) on the NHS
17 March 2017 - The Department of Health has asked NICE to produce guidance on the use of daratumumab as monotherapy ...
Posted by Michael Wonder on 16 Mar 2017
Call for feedback: new drugs for type 2 diabetes: second-line therapy : a therapeutic review update
15 March 2017 - A report on new drugs for second-line therapy for 2 diabetes: a therapeutic review update is now ...
Posted by Michael Wonder on 16 Mar 2017
NICE gets go-ahead to fast-track more drug approvals
15 March 2017 - Patients will benefit from access to the most cost-effective treatments nearly 5 months faster after changes to ...
Posted by Michael Wonder on 16 Mar 2017
NHS to introduce £20 milion cap on new drugs
15 March 2017 - A new £20 million/year cap on the cost of new drugs will be introduced in the ...
Posted by Michael Wonder on 16 Mar 2017
New UK drug cost rules leave companies fuming
16 March 2017 - British drugmakers on Wednesday accused Theresa May's Conservative government of breaking a manifesto commitment to improve ...
Posted by Michael Wonder on 15 Mar 2017
NICE publishes draft guidance on the use of adalimumab and dexamethasone for uveitis
15 March 2017 - The Department of Health has asked NICE to produce guidance on the use of adalimumab and dexamethasone ...
Posted by Michael Wonder on 15 Mar 2017
New CADTH guidelines for the economic evaluation of health technologies
15 March 2017 - Join CADTH in person or online on Tuesday, 28 March 2017 as they release the fourth ...
Posted by Michael Wonder on 15 Mar 2017
Medibank skips health insurance grilling
15 March 2017 - Medibank won't join other health funds to explain soaring private health insurance premiums at a parliamentary ...
Posted by Michael Wonder on 15 Mar 2017
Sanofi displeased with NICE decision on rare disease drug
14 March 2017 - French drug major Sanofi and its specialty care global business unit, Sanofi Genzyme, say they are ...